Wordt geladen...
Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models
INTRODUCTION: Targeting receptor tyrosine kinases (RTKs) with kinase inhibitors is a clinically validated anti-cancer approach. However, blocking one signaling pathway is often not sufficient to cause tumor regression and the effectiveness of individual inhibitors is often short-lived. As alteration...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672810/ https://ncbi.nlm.nih.gov/pubmed/23343422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3379 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|